MedPath

Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax

Not Applicable
Terminated
Conditions
Astigmatism
Myopia
Interventions
Procedure: Topography Guided LASIK
Procedure: Small Incision Lenticular Extraction
Device: WaveLight EX500 Excimer Laser System
Device: VisuMax Surgical Laser
Registration Number
NCT02987660
Lead Sponsor
Alcon, a Novartis Company
Brief Summary

The purpose of this study is to compare Topography Guided Laser In Situ Keratomileusis (LASIK) corneal surgery to Small Incision Lenticule Extraction (SMILE) corneal surgery for the treatment of myopia with astigmatism.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Subjects in Singapore must be 21 years of age or older and subjects in Korea must be upon completion of 19 years of age or older due to local regulations;
  • Able to comprehend and sign an informed consent form;
  • Willing and able to complete all postoperative visits;
  • Myopia requiring (a) refractive error correction of -0.5 to -8.0 D optical infinity adjusted manifest refraction sphere with (b) astigmatism correction of -0.75 to -5.0 D manifest refraction cylinder and (c) at least 0.75 D of corneal astigmatism.
  • Intended treatment targeted for emmetropia;
  • Preoperative best-corrected visual acuity (BCVA) of 0 logMAR or better;
  • Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
  • Pregnant or lactating, current or planned, during the course of the study;
  • Dry eye;
  • Corneal disease;
  • Diagnosis of advanced glaucoma;
  • Uncontrolled diabetes;
  • Other protocol-defined exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LASIK with EX500Topography Guided LASIKTopography Guided LASIK with WaveLight EX500 excimer laser system in bilateral surgery
LASIK with EX500WaveLight EX500 Excimer Laser SystemTopography Guided LASIK with WaveLight EX500 excimer laser system in bilateral surgery
SMILE with VisuMaxSmall Incision Lenticular ExtractionSmall incision lenticular extraction (SMILE) with VisuMax laser in bilateral surgery
SMILE with VisuMaxVisuMax Surgical LaserSmall incision lenticular extraction (SMILE) with VisuMax laser in bilateral surgery
Primary Outcome Measures
NameTimeMethod
Percentage of Eyes With Manifest Refraction Cylinder Less Than or Equal to 0.5 Diopter (D) at 3 MonthsMonth 3

Manifest refraction cylinder was measured monocularly (each eye separately) at 3 or 4 meters (m) under photopic lighting conditions using a phoropter and Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The manifest refraction at 4 m or 3 m was adjusted for optical infinity by adding -0.25 D to the sphere value. Both eyes contributed to the analysis. Since the study was terminated early, inferential statistics could not be completed.

Secondary Outcome Measures
NameTimeMethod
Mean Manifest Refraction Cylinder at 3 MonthsMonth 3

Manifest refraction cylinder was measured monocularly at 3 or 4 meters under photopic lighting conditions using a phoropter and ETDRS chart. The manifest refraction at 4 m or 3 m was adjusted for optical infinity by adding -0.25 D to the sphere value. Both eyes contributed to the analysis. Since the study was terminated early, inferential statistics could not be completed.

Mean Uncorrected Visual Acuity (UCVA) at 3 MonthsMonth 3

Uncorrected (without spectacles or other visual corrective devices) Visual Acuity (UCVA) testing was conducted monocularly in photopic conditions without glare at 3 or 4 meters. Visual Acuity (VA) is measured in "logarithm of the minimum angle of resolution" (logMAR). A lower logMAR value indicates better visual acuity. The Precision Vision illuminator cabinets and ETDRS charts were used. For subjects who could not read English letters, a numerical, Tumbling E logMAR chart was used. Since the study was terminated early, inferential statistics could not be completed.

Trial Locations

Locations (1)

Alcon Investigative Site

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath